27328-69-4Relevant academic research and scientific papers
THERAPEUTIC INHIBITORY COMPOUNDS
-
Page/Page column 42, (2015/07/16)
The invention provides compounds of Formula I and Formula II: A-B-C-D-E-F-G-J (I) C-D-E-F-G-J (II) wherein A, B, C, D, E, F, G, and J have any of the values defined in the specification, and salts thereof. The compounds are useful for inhibiting plasma kallikrein, and for treating a disease or condition in an animal where inhibition of plasma kallikrein is indicated.
5-MEMBERED HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
-
Page/Page column 43, (2013/08/15)
The invention relates to a compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
Novel thrombin inhibitors
-
Page/Page column 14; 16-17, (2008/06/13)
The invention relates to compounds of formula (I) wherein A, B, R1, R2, G, R3, D and E have the meaning as cited in the description and the claims. Said compounds are useful as coagulants. The invention also relates to the
DPP-IV INHIBITORS
-
Page/Page column 50-51, (2010/02/14)
The invention relates to compounds of formula (I), Z-C(R1R 2)-C(R3NH2)-C(R4R5)-X-N(R 6R7), wherein Z, R1-7 and X have the meaning as cited in the description and the claims. Said compounds are useful as DPP-lV inhibitors. The invention also relates to the
SIMPLE SYNTHESIS OF 3-ALKYL-1H-INDAZOLES HAVING FUNCTIONAL GROUPS AT THE ω-POSITION
Sasakura, Kazuyuki,Kawasaki, Akiko,Sugasawa, Tsutomu
, p. 259 - 264 (2007/10/02)
3-Alkyl-1H-indazoles (1) having a functional group at the ω-position can be simply synthesized by using 2-(ω-chloroalkanoyl)anilines (3) as starting material.
